Latest Ratings for KPTI
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 2022 | RBC Capital | Maintains | Sector Perform | |
| Mar 2022 | SVB Leerink | Maintains | Market Perform | |
| Feb 2022 | JP Morgan | Upgrades | Underweight | Neutral |
These Analysts Revise Their Forecasts On Karyopharm Therapeutics After Q1 Results
